Ascelia Pharma AB (ACELP)

Currency in SEK
4.485
+0.020(+0.45%)
Closed·
ACELP Scorecard
Full Analysis
Net income is expected to grow this year
ACELP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.4004.570
52 wk Range
1.8895.000
Key Statistics
Prev. Close
4.465
Open
4.47
Day's Range
4.4-4.57
52 wk Range
1.889-5
Volume
894.8K
Average Vol. (3m)
966.72K
1-Year Change
42.96%
Book Value / Share
0.6
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ACELP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Ascelia Pharma AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Ascelia Pharma AB Company Profile

Ascelia Pharma AB (publ), a biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden. It develops Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 clinical trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, that is in Phase 2 clinical trial for the treatment of gastric cancer. The company has a collaboration agreement with the Taiho Oncology Inc. Ascelia Pharma AB (publ) was incorporated in 1999 and is headquartered in Malmö, Sweden.

Compare ACELP to Peers and Sector

Metrics to compare
ACELP
Peers
Sector
Relationship
P/E Ratio
−6.1x−9.1x−0.5x
PEG Ratio
−0.11−0.180.00
Price / Book
9.0x6.3x2.6x
Price / LTM Sales
-40.2x3.2x
Upside (Analyst Target)
44.9%17.2%44.6%
Fair Value Upside
Unlock2.3%6.5%Unlock

Earnings

Latest Release
May 16, 2025
EPS / Forecast
-0.20 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ACELP Income Statement

FAQ

What Is the Ascelia Pharma (ACELP) Stock Price Today?

The Ascelia Pharma stock price today is 4.49

What Stock Exchange Does Ascelia Pharma Trade On?

Ascelia Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Ascelia Pharma?

The stock symbol for Ascelia Pharma is "ACELP."

What Is the Ascelia Pharma Market Cap?

As of today, Ascelia Pharma market cap is 520.37M.

What Is Ascelia Pharma's Earnings Per Share (TTM)?

The Ascelia Pharma EPS (TTM) is -1.22.

When Is the Next Ascelia Pharma Earnings Date?

Ascelia Pharma will release its next earnings report on Aug 21, 2025.

From a Technical Analysis Perspective, Is ACELP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Ascelia Pharma Stock Split?

Ascelia Pharma has split 0 times.

How Many Employees Does Ascelia Pharma Have?

Ascelia Pharma has 11 employees.

What is the current trading status of Ascelia Pharma (ACELP)?

As of Jul 19, 2025, Ascelia Pharma (ACELP) is trading at a price of 4.49, with a previous close of 4.47. The stock has fluctuated within a day range of 4.40 to 4.57, while its 52-week range spans from 1.89 to 5.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.